ADVANCED SOLID TUMOR CANCER
Clinical trials for ADVANCED SOLID TUMOR CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED SOLID TUMOR CANCER trials appear
Sign up with your email to follow new studies for ADVANCED SOLID TUMOR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New Triple-Action therapy takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage trial is testing a new treatment called X-PACT for people with advanced head and neck cancer, breast cancer, soft tissue sarcoma, or melanoma. The treatment involves injecting a special drug and tiny light-producing particles directly into the tumor, then exposin…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Immunolight, LLC • Aim: Disease control
Last updated May 26, 2026 09:19 UTC
-
New cancer drug BNT3214 enters first human trials
Disease control Recruiting nowThis study tests a new drug called BNT3214 for the first time in people with advanced solid tumors. The goal is to find the safest dose and see if it can shrink tumors. About 533 adults will take part in three phases: first finding the right dose, then testing it in different can…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1, PHASE2 • Sponsor: BioNTech SE • Aim: Disease control
Last updated May 26, 2026 08:58 UTC
-
New hope for hard-to-treat cancers: targeted drug shows promise in early trial
Disease control Recruiting nowThis study tests a new drug called trastuzumab rezetecan in people with advanced solid tumors that are HER2-positive and have not responded to standard therapies. The trial includes 90 participants with three types of cancer: extramammary Paget's disease, rare solid tumors, or ur…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: Sheng Zhang • Aim: Disease control
Last updated May 26, 2026 08:19 UTC
-
New drug combo aims to shrink Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called HC010 combined with chemotherapy in people with advanced solid tumors that have spread or cannot be removed by surgery. The main goal is to find a safe dose and check for side effects. About 331 participants will take part, and resea…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New combo therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis study tests a new drug called LM-24C5 combined with other cancer treatments for people with advanced solid tumors that have a specific protein (CEACAM5). The goal is to see if the combination shrinks tumors and is safe. About 130 adults aged 18-80 whose cancer has returned o…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE2 • Sponsor: LaNova Medicines Limited • Aim: Disease control
Last updated May 19, 2026 11:47 UTC
-
New drug combo hopes to shrink lung tumors
Disease control Recruiting nowThis early-stage study tests a new drug called HC010 combined with chemotherapy in people with advanced lung cancer. The main goal is to find a safe dose and see if the combination helps control the disease. About 328 participants will take part.
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: HC Biopharma Inc. • Aim: Disease control
Last updated May 18, 2026 12:07 UTC
-
New drug combo shows promise in early cancer trial
Disease control Recruiting nowThis early-phase study tests a new drug, ABBV-CLS-484, alone or combined with other cancer treatments, in people with advanced solid tumors that have not responded to standard therapy. The goal is to find a safe dose and see if the drug can shrink tumors. About 248 adults with ce…
Matched conditions: ADVANCED SOLID TUMOR CANCER
Phase: PHASE1 • Sponsor: Calico Life Sciences LLC • Aim: Disease control
Last updated May 18, 2026 12:02 UTC